Effects of carbamazepine on 5-hydroxytryptamine function in rodents

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Carbamazepine (CBZ) is an anticonvulsant and mood-stabilizing drug.
• Its precise effects on central serotonergic (5-hydroxytryptamine, 5-HT) neurotransmission require further elucidation.

Purpose of the Study:

• To investigate the impact of acute and chronic carbamazepine administration on various aspects of 5-HT function in rodent models.
• To assess behavioral responses, neurotransmitter synthesis, and neurotransmitter release.

Main Methods:

• Rodents (mice and rats) were pretreated with CBZ (acute or 14 days).
• Behavioral tests included head-twitch response (5-HT2), 8-OH-DPAT-induced syndrome and hypothermia (5-HT1A), and tranylcypromine/L-tryptophan-induced behaviors.
• 5-HT synthesis was measured via 5-HTP accumulation after NSD1015.
• Potassium-stimulated [3H]-5-HT release and 5-HT2 binding were assessed in brain slices.

Main Results:

• Chronic CBZ increased 5-HT2-mediated head twitches but not responses to a direct agonist.
• CBZ did not alter 5-HT1A receptor-mediated behaviors or hypothermia.
• CBZ pretreatment reduced hyperactivity induced by tranylcypromine/L-tryptophan.
• Acute CBZ decreased 5-HTP accumulation, but chronic CBZ did not affect 5-HT synthesis.
• Chronic CBZ enhanced potassium-stimulated [3H]-5-HT release from hippocampal slices.

Conclusions:

• Carbamazepine exerts complex effects on 5-HT neurotransmission, modulating specific receptor-mediated behaviors and neurotransmitter release.
• Chronic CBZ treatment appears to enhance presynaptic 5-HT release in the hippocampus.
• Findings suggest CBZ's therapeutic effects may involve modulation of serotonergic pathways.